Filing Flows › Exagen (XGN) › Q1 2026 › vs Q1 2025
Exagen (XGN) Q1 2026 vs Q1 2025 (year over year)
Exagen's revenue rose $1.8M (+12%) from $15.5M in Q1 2025 to $17.3M in Q1 2026.
Exagen, Q1 2026: revenue $17.3M (+12% year over year), operating margin -19.7%, net loss $4.0M, operating cash flow −$10.4M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $17.3M | $15.5M | $1.8M | +12% |
| Net loss | $4.0M | $3.8M | $215K | +6% |
| Costs & expenses | $21.3M | $19.2M | $2.0M | +11% |
| Operating costs | $20.7M | $18.9M | $1.9M | +10% |
| Interest & other, net | $517K | $387K | $130K | +34% |
| Income tax | $36K | $0 | $36K | — |
| Cost of revenue | $7.1M | $6.4M | $726K | +11% |
| Research & development | $1.6M | $1.3M | $269K | +21% |
| SG&A | $12.1M | $11.2M | $862K | +8% |
| Operating cash sources | $11.7M | $11.5M | $184K | +2% |
| Depreciation & amortization | $600K | $400K | $200K | +50% |
| Share-based compensation | $655K | $417K | $238K | +57% |
| Cash used in operations | $10.4M | $10.7M | −$254K | -2% |
| Net loss absorbed | $4.0M | $3.8M | $215K | +6% |
| Working capital & other | $7.7M | $7.7M | −$31K | -0.4% |
Questions
How much did Exagen's revenue grow year over year in Q1 2026?
Exagen's revenue rose $1.8M (+12%) from $15.5M in Q1 2025 to $17.3M in Q1 2026.